A randomized controlled trial of antibiotics targeting adherent and invasive Escherichia coli versus placebo in Crohn’s disease: the TEOREM trial

医学 克罗恩病 安慰剂 抗生素 内科学 大肠杆菌 随机对照试验 疾病 胃肠病学 病理 微生物学 替代医学 生物化学 化学 基因 生物
作者
Franck Carbonnel,Nicolas Barnich,Patricia Lepage,Xavier Hébuterne,Christophe Michiels,Cyrielle Gilletta,Pauline Wils,David Laharie,Romain Altwegg,Matthieu Allez,Yoram Bouhnik,Antoine Meyer,Clémence Breton,Hélène Agostini,Domitille Molinari,Ryan Balfour Sartor,Jean‐Yves Mary,Jean‐Frédéric Colombel,Caroline Chevarin,Fréderic Faure
出处
期刊:Journal of Crohn's and Colitis [Oxford University Press]
卷期号:19 (7): jjaf093- 被引量:7
标识
DOI:10.1093/ecco-jcc/jjaf093
摘要

BACKGROUND: A subset of patients with ileal Crohn's disease (CD) are colonized with adherent-invasive Escherichia coli (AIEC). OBJECTIVE: This prospective trial tested the efficacy of antibiotics for endoscopic response in CD patients colonized with AIEC. DESIGN: Patients with endoscopically active, ileal CD, colonized with AIEC, were randomized to receive oral ciprofloxacin and rifaximin or double placebo for 12 weeks. AIEC was detected in ileal biopsies, by phenotypic analysis. The primary endpoint was endoscopic overall response, as defined by a CD endoscopic index of severity adapted to patients with ileal CD. Central readers blinded to the treatment scored video recordings of colonoscopies at preinclusion and week 12. We expected a strong signal of efficacy for antibiotics in this subgroup of patients. RESULTS: Between May 2016 and June 2021, 155 patients were screened, and 24 patients were randomized, 12 in each arm. All patients' AIEC were sensitive to ciprofloxacin and rifaximin in vitro. There was no statistical difference between the 2 arms for endoscopic overall response (50% in the Cipro-Rifa group vs 33% in the placebo group, estimated difference 17%; 95% CI, -23% to 51%). Within the antibiotics arm, 7/10 patients became AIEC- and 3/10 patients remained AIEC+ (and acquired resistance to ciprofloxacin), as compared to 7/12 AIEC- and 5/12 AIEC+ in the placebo arm, respectively. There was no association between AIEC clearance and endoscopic endpoints. CONCLUSIONS: A combination of ciprofloxacin and rifaximin was not superior to placebo to achieve endoscopic endpoints in patients with ileal CD colonized with AIEC.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
刚刚
摸鱼帝王完成签到,获得积分10
1秒前
momo完成签到,获得积分10
1秒前
1秒前
科研通AI6.4的应助被鱼鱼子采纳,获得10
1秒前
Aourp完成签到,获得积分10
1秒前
1秒前
chen完成签到,获得积分10
1秒前
yyyyyy发布了新的文献求助10
1秒前
2秒前
xiaofeng发布了新的文献求助10
2秒前
英姑的应助被tt采纳,获得10
2秒前
雪维发布了新的文献求助20
2秒前
共享精神的应助被搞怪的乐荷采纳,获得10
2秒前
sichub完成签到 ,获得积分10
2秒前
3秒前
栗松琛发布了新的文献求助10
3秒前
DONNYTIO发布了新的文献求助10
3秒前
3秒前
4秒前
4秒前
Felicity5完成签到,获得积分10
4秒前
领导范儿的应助被我真的晕采纳,获得10
4秒前
4秒前
Sakura完成签到,获得积分10
5秒前
5秒前
Akim的应助被郝煜祺采纳,获得10
5秒前
5秒前
qiuqiu815777完成签到,获得积分10
5秒前
40780完成签到,获得积分10
5秒前
Wy21完成签到,获得积分10
5秒前
WF发布了新的文献求助10
5秒前
6秒前
6秒前
美满雨琴发布了新的文献求助10
6秒前
JamesPei的应助被清河聂氏采纳,获得10
6秒前
DongQiu1993发布了新的文献求助10
6秒前
亚男66完成签到,获得积分10
7秒前
7秒前
7秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1500
The World Atlas of Wine 9th edition 1000
奈特基础组织学:配套组织病理学(第4版)(Netter's Essential Histology With Correlated Histopathology) 800
John McDowells Bildungstheorie 800
八旗制度の研究 600
Analyses de reconnaissances de dettes passées devant les échevins d'Ypres (1249-1291) 600
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8160467
求助须知:如何正确求助?哪些是违规求助? 9555463
关于积分的说明 21728123
捐赠科研通 7750270
什么是DOI,文献DOI怎么找? 3427393
关于科研通互助平台的介绍 2552425
邀请新用户注册赠送积分活动 2471741